The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 21, 2020

Filed:

Sep. 14, 2016
Applicant:

Curemark, Llc, Rye Brook, NY (US);

Inventors:

Joan M. Fallon, White Plains, NY (US);

Matthew Heil, Sherman, CT (US);

James Fallon, Armonk, NY (US);

James Szigethy, Montgomery, NY (US);

Assignee:

CUREMARK, LLC, Rye Brook, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/54 (2006.01); A61K 38/47 (2006.01); A61K 38/48 (2006.01); A61K 38/46 (2006.01); A61K 9/00 (2006.01); A61K 39/145 (2006.01); A61K 39/00 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/54 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 38/465 (2013.01); A61K 38/47 (2013.01); A61K 38/4826 (2013.01); A61K 38/4873 (2013.01); A61K 39/145 (2013.01); C12N 7/00 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/5254 (2013.01); C12N 2760/16134 (2013.01);
Abstract

This disclosure relates to the prevention and treatment of Influenza, and more particularly Influenza A Virus Subtype H1N1, with the use of a pharmaceutical composition comprising one or more digestive enzymes, such as pancreatic enzymes and porcine pancreatic enzymes. The disclosure further relates to the use of an individual's fecal chymotrypsin level as an indicator, e.g., biomarker of whether an individual may be more susceptible to Influenza, e.g., Influenza A Subtype H1N1, and/or whether an individual will benefit from administration of the described pharmaceutical compositions. Use of the compositions as sanitizers, antiseptics, disinfectants, and detergents, e.g., to reduce or eradicate influenza virus present on living or inanimate surfaces is also contemplated.


Find Patent Forward Citations

Loading…